Michael Listgarten Named General Counsel of ALX Oncology

Michael Listgarten was named General Counsel of ALX Oncology on June 30, 2026, according to an SEC filing.

NameMichael Listgarten
RoleGeneral Counsel
CompanyALX Oncology
IndustryBiotechnology
LocationSouth San Francisco, CA
MoveAppointment
DateJune 30, 2026
Sourcean SEC filing

ALX Oncology appointed Michael Listgarten as General Counsel effective June 30, 2026. He previously served as Vice President of Healthcare Law and Chief Compliance Officer at Adamas Pharmaceuticals, held a healthcare law role at Principia Biopharma, and spent 16 years at Genentech. (Source: an SEC filing.)

Who is the general counsel of ALX Oncology?

Michael Listgarten took the General Counsel role at ALX Oncology in June 2026, as reported by an SEC filing. Legal leadership changes often, so check ALX Oncology’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.

Other general counsel moves in June 2026

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.